The Swiss biotech company Idorsia announced this week that it has received approval from the United States Food and Drug Administration (FDA) for its new drug that can help adult patients treat […]
The FDA grants approval for a new insomnia drug to improve sleep in adults Read More »
Project “Development of a Cloud Platform for Patient-Oriented Telerehabilitation of Cancer Patients Based on Mathematical Modeling” Won in the Competition On December 7, 2021, the Scientific Council of National Research
Novavax, a Maryland-based biotechnology company, gets approval for its more traditional protein-subunit COVID-19 vaccine, offering an alternative to newer mRNA and viral vector vaccine options. Pfizer-BioNTech’s COVID-19 vaccine is the
Pfizer executives predict COVID will be endemic as early as 2024. What does COVID’s endemicity look like? Much like the flu, where more predictable patterns of outbreaks occur seasonally, with fewer
COVID Predicted to be Endemic by 2024 Read More »
On December 7, 2021, the Scientific Council of National Research Foundation of Ukraine published the ranking of projects joining the competition “Science for Security and Sustainable Development of Ukraine”, which
Per- and polyfluoroalkyl substances (PFAS) have been in the news recently. The United States Environmental Protection Agency recently released a three-year plan to study and regulate these “forever chemicals,” which have been
PFAS Found Entering the Atmosphere via Sea Spray Read More »
We’ve long known that there are bacteria in the human gut; some can be dangerous if they are ingested. But genetic and computational technologies have advanced rapidly in recent years,
To Understand the Gut Microbiome, Researchers Create New Method to ID Strains Read More »
Anthrax conjures thoughts of bioterrorism, though it’s a disease caused by a rare but naturally-occurring bacterium, Bacillus anthracis. Scientists have now found that a toxin produced by the infectious pathogen could
Anthrax Toxin Has Potential as Non-Opioid Pain Therapeutic Read More »
